176 related articles for article (PubMed ID: 18204077)
1. Activation of RON differentially regulates claudin expression and localization: role of claudin-1 in RON-mediated epithelial cell motility.
Zhang K; Yao HP; Wang MH
Carcinogenesis; 2008 Mar; 29(3):552-9. PubMed ID: 18204077
[TBL] [Abstract][Full Text] [Related]
2. Collaborative activities of macrophage-stimulating protein and transforming growth factor-beta1 in induction of epithelial to mesenchymal transition: roles of the RON receptor tyrosine kinase.
Wang D; Shen Q; Chen YQ; Wang MH
Oncogene; 2004 Mar; 23(9):1668-80. PubMed ID: 15001985
[TBL] [Abstract][Full Text] [Related]
3. Activation of the RON receptor tyrosine kinase attenuates transforming growth factor-beta1-induced apoptotic death and promotes phenotypic changes in mouse intestinal epithelial cells.
Wang D; Shen Q; Xu XM; Chen YQ; Wang MH
Carcinogenesis; 2005 Jan; 26(1):27-36. PubMed ID: 15447977
[TBL] [Abstract][Full Text] [Related]
4. Deletion or insertion in the first immunoglobulin-plexin-transcription (IPT) domain differentially regulates expression and tumorigenic activities of RON receptor Tyrosine Kinase.
Ma Q; Zhang K; Guin S; Zhou YQ; Wang MH
Mol Cancer; 2010 Nov; 9():307. PubMed ID: 21114864
[TBL] [Abstract][Full Text] [Related]
5. Alterations in a defined extracellular region of the RON receptor tyrosine kinase promote RON-mediated motile and invasive phenotypes in epithelial cells.
Zhang K; Zhou YQ; Yao HP; Wang MH
Int J Oncol; 2010 Jan; 36(1):255-64. PubMed ID: 19956854
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of RON-mediated epithelial-mesenchymal transition in MDCK cells through the MAPK pathway.
Xiangming X; Yun Q; Guoliang Z; Jianjiang L; Lisong T
Braz J Med Biol Res; 2011 Jul; 44(7):634-41. PubMed ID: 21655705
[TBL] [Abstract][Full Text] [Related]
7. Extracellular signal-regulated kinases 1/2 control claudin-2 expression in Madin-Darby canine kidney strain I and II cells.
Lipschutz JH; Li S; Arisco A; Balkovetz DF
J Biol Chem; 2005 Feb; 280(5):3780-8. PubMed ID: 15569684
[TBL] [Abstract][Full Text] [Related]
8. The transcription factors Slug and Snail act as repressors of Claudin-1 expression in epithelial cells.
Martínez-Estrada OM; Cullerés A; Soriano FX; Peinado H; Bolós V; Martínez FO; Reina M; Cano A; Fabre M; Vilaró S
Biochem J; 2006 Mar; 394(Pt 2):449-57. PubMed ID: 16232121
[TBL] [Abstract][Full Text] [Related]
9. Proinflammatory cytokines tumor necrosis factor-alpha and interferon-gamma modulate epithelial barrier function in Madin-Darby canine kidney cells through mitogen activated protein kinase signaling.
Patrick DM; Leone AK; Shellenberger JJ; Dudowicz KA; King JM
BMC Physiol; 2006 Feb; 6():2. PubMed ID: 16504032
[TBL] [Abstract][Full Text] [Related]
10. Recepteur d'origine nantais tyrosine kinase is a direct target of hypoxia-inducible factor-1alpha-mediated invasion of breast carcinoma cells.
Thangasamy A; Rogge J; Ammanamanchi S
J Biol Chem; 2009 May; 284(21):14001-10. PubMed ID: 19307182
[TBL] [Abstract][Full Text] [Related]
11. Oncogenesis of RON receptor tyrosine kinase: a molecular target for malignant epithelial cancers.
Wang MH; Yao HP; Zhou YQ
Acta Pharmacol Sin; 2006 Jun; 27(6):641-50. PubMed ID: 16723080
[TBL] [Abstract][Full Text] [Related]
12. RNA-mediated gene silencing of the RON receptor tyrosine kinase alters oncogenic phenotypes of human colorectal carcinoma cells.
Xu XM; Wang D; Shen Q; Chen YQ; Wang MH
Oncogene; 2004 Nov; 23(52):8464-74. PubMed ID: 15378025
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor activation differentially regulates claudin expression and enhances transepithelial resistance in Madin-Darby canine kidney cells.
Singh AB; Harris RC
J Biol Chem; 2004 Jan; 279(5):3543-52. PubMed ID: 14593119
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel recepteur d'origine nantais/c-met small-molecule kinase inhibitor with antitumor activity in vivo.
Zhang Y; Kaplan-Lefko PJ; Rex K; Yang Y; Moriguchi J; Osgood T; Mattson B; Coxon A; Reese M; Kim TS; Lin J; Chen A; Burgess TL; Dussault I
Cancer Res; 2008 Aug; 68(16):6680-7. PubMed ID: 18701492
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase.
Wang MH; Wang D; Chen YQ
Carcinogenesis; 2003 Aug; 24(8):1291-300. PubMed ID: 12807733
[TBL] [Abstract][Full Text] [Related]
16. The RON receptor tyrosine kinase promotes MSP-independent cell spreading and survival in breast epithelial cells.
Feres KJ; Ischenko I; Hayman MJ
Oncogene; 2009 Jan; 28(2):279-88. PubMed ID: 18836480
[TBL] [Abstract][Full Text] [Related]
17. RON receptor tyrosine kinase in human gliomas: expression, function, and identification of a novel soluble splice variant.
Eckerich C; Schulte A; Martens T; Zapf S; Westphal M; Lamszus K
J Neurochem; 2009 May; 109(4):969-80. PubMed ID: 19519771
[TBL] [Abstract][Full Text] [Related]
18. Chrysin inhibits cell invasion by inhibition of Recepteur d'origine Nantais via suppressing early growth response-1 and NF-κB transcription factor activities in gastric cancer cells.
Xia Y; Lian S; Khoi PN; Yoon HJ; Han JY; Chay KO; Kim KK; Jung YD
Int J Oncol; 2015 Apr; 46(4):1835-43. PubMed ID: 25625479
[TBL] [Abstract][Full Text] [Related]
19. Significance of the entire C-terminus in biological activities mediated by the RON receptor tyrosine kinase and its oncogenic variant RON160.
Lu Y; Yao HP; Wang MH
J Exp Clin Cancer Res; 2008 Oct; 27(1):55. PubMed ID: 18950514
[TBL] [Abstract][Full Text] [Related]
20. Human RON receptor tyrosine kinase induces complete epithelial-to-mesenchymal transition but causes cellular senescence.
Côté M; Miller AD; Liu SL
Biochem Biophys Res Commun; 2007 Aug; 360(1):219-25. PubMed ID: 17588532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]